Skip to main content

Zacharias Isaac's Form 4 filing

Shockwave Medical, Inc.SWAV · filed Jul 16, 2021

Accession no.
0000950103-21-010605
Filed
Jul 16, 2021
Trade date
Jul 15, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 10 non-derivative transactions and 1 derivative transaction. Open-market sales total $662.0K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Zacharias IsaacCIK 0001768265Officer (Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 15, 2021Common StockMOption exerciseAcquired+4,000$6.71+$26,84063,420Direct
Jul 15, 2021Common StockSSaleDisposed−368$160.56F2−$59,086.0863,052Direct
Jul 15, 2021Common StockSSaleDisposed−200$161.64F3−$32,32862,852Direct
Jul 15, 2021Common StockSSaleDisposed−100$162.41F4−$16,24162,752Direct
Jul 15, 2021Common StockSSaleDisposed−895$164.28F5−$147,030.661,857Direct
Jul 15, 2021Common StockSSaleDisposed−600$165.15F6−$99,09061,257Direct
Jul 15, 2021Common StockSSaleDisposed−1,000$166.51F7−$166,51060,257Direct
Jul 15, 2021Common StockSSaleDisposed−500$168.41F8−$84,20559,757Direct
Jul 15, 2021Common StockSSaleDisposed−100$169.14F9−$16,91459,657Direct
Jul 15, 2021Common StockSSaleDisposed−237$171.11F10−$40,553.0759,420Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 15, 2021Common StockMOption exerciseDisposed−4,000$0.00$056,322Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $160.30 to $160.92. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $161.38 to $161.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F4

The reported securities were sold at a price of $162.41

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $163.89 to $164.74. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $164.96 to $165.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $166.01 to $166.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $168.02 to $168.90. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

F9

The reported securities were sold at a price of $169.14.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $171.00 to $171.68. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)